Search Results

The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science are excited to announce a partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the development of safe, non-invasive ways of treating neurodegenerative and neuropsychiatric disorders.

Heartbeat Health, the nation’s largest decentralized cardiology provider, and Karoo Health, the only operational provider of cardiac value-based care enablement with published value-based results, announced the formation of a unique value-based enterprise, creating the first national, scalable, end-to-end cardiac value-based care solution for payers, at-risk entities, and provider networks.

Castle Biosciences, Inc. announced that it has been selected as the winner of the “Best Overall Mental Health Solution” award in the eighth annual MedTech Breakthrough Awards program for its IDgenetix® pharmacogenomic test.

Toronto, Ontario--(Newsfile Corp. - April 9, 2024) - SRx Health Solutions Inc., a leading Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry

Health Canada authorizes Tecentriq SC (atezolizumab, solution for subcutaneous injection), the first cancer immunotherapy subcutaneous injection, for multiple cancer types.

Agitated Solutions, Incorporated announced that it has been issued a Medical Device Establishment License from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.

Praia Health, a consumer platform for delivering individualized health solutions at scale, announced today a new partnership with CLEAR, the secure identity company, to enhance identity verification processes for health systems.

The American Cancer Society and Color Health announced an expansion of their program to form a comprehensive cancer solution for employers and labor unions to support their employee and member populations across all stages of the cancer journey.

Remidio Inc., a health technology innovator developing cutting-edge technology to combat global blindness from Diabetic Retinopathy, Glaucoma, AMD, & Cataracts, is all set to achieve a significant milestone.